The successful use of plasma exchange and immunosuppression in the management of acquired Glanzmann's thrombasthenia.
Thomas
R V
RV
Bessos
H
H
Turner
M L
ML
Horn
E H
EH
Ludlam
C A
CA
D000925:Anticoagulants / Q000009:adverse effects; D001379:Azathioprine / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy / Q000209:etiology; D006493:Heparin / Q000009:adverse effects; D024764:Hirudin Therapy / Q000379:methods; D006801:Humans; D007084:Iliac Vein; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008875:Middle Aged; D010951:Plasma Exchange / Q000379:methods*; D013915:Thrombasthenia / Q000628:therapy*; D013921:Thrombocytopenia / Q000139:chemically induced; D020246:Venous Thrombosis / Q000139:chemically induced / Q000188:drug therapy
D000925:Anticoagulants; D007166:Immunosuppressive Agents; D006493:Heparin; D001379:Azathioprine